PATENT CLAIM ANALYSIS

Application Number: 15917555
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "275000"]

Abstract:
Provided are compounds having HDAC6 modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by HDAC6.

Claim (Index 51):
A method of treating a subject suffering from or susceptible to a disorder or disease, wherein the subject has been identified as in need of treatment for the disorder or disease, comprising administering to said subject in need thereof, an effective amount of a compound of  claim 1 , or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 74.0
- Percentile: 90.0
- Lexical Diversity: 1.1
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15763972', '15858015', '15815809', '15857950', '12843702']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7604751248388897
- 35 USC 102 Novelty (BERT): 0.5514563060917084
- Combined Prediction Score: 0.7395732429641716
- Mean Citation Score: 381.424428
- Max Citation Score: 410.94333
- Similarity Product: 299.7017144851577

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test